Helix Biopharma Corp Stock Today
| HBP Stock | CAD 0.18 0.02 10.00% |
Performance0 of 100
| Odds Of DistressOver 68
|
Helix BioPharma is selling at 0.18 as of the 19th of April 2024; that is -10% down since the beginning of the trading day. The stock's open price was 0.2. Helix BioPharma has more than 68 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Helix BioPharma Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of April 2023 and ending today, the 19th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Helix BioPharma Corp., an immune-oncology company, focuses on the development of cancer drugs in Canada. Helix BioPharma Corp. is headquartered in Richmond Hill, Canada. HELIX BIOPHARM operates under Biotechnology classification in Canada and is traded on Toronto Stock Exchange. The company has 229.44 M outstanding shares of which 1.89 K shares are currently shorted by private and institutional investors with about 0.13 days to cover all short positions. More on Helix BioPharma Corp
Moving against Helix Stock
| 0.49 | CET | Cathedral Energy Services | PairCorr |
| 0.44 | CDAY | Ceridian HCM Holding | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Helix Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Helix BioPharma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Helix BioPharma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO and Pres | Zbigniew Markowski | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
Helix BioPharma's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Helix BioPharma's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Helix BioPharma's financial leverage. It provides some insight into what part of Helix BioPharma's total assets is financed by creditors.
| |||||
Helix BioPharma Corp (HBP) is traded on Toronto Exchange in Canada and employs 9 people. Helix BioPharma is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 40.15 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Helix BioPharma's market, we take the total number of its shares issued and multiply it by Helix BioPharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Helix BioPharma Corp operates under Biotechnology sector and is part of Health Care industry. The entity has 229.44 M outstanding shares of which 1.89 K shares are currently shorted by private and institutional investors with about 0.13 days to cover all short positions.
Helix BioPharma Corp has accumulated about 938 K in cash with (5.53 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check Helix BioPharma Probability Of Bankruptcy
Ownership AllocationHelix BioPharma secures a total of 229.44 Million outstanding shares. Helix BioPharma secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Helix Ownership Details
Helix Stock Price Odds Analysis
Contingent on a normal probability distribution, the odds of Helix BioPharma jumping above the current price in 90 days from now is about 76.89%. The Helix BioPharma Corp probability density function shows the probability of Helix BioPharma stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Helix BioPharma Corp has a beta of -1.811. This usually indicates as returns on its benchmark rise, returns on holding Helix BioPharma Corp are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Helix BioPharma is expected to outperform its benchmark. Additionally, helix BioPharma Corp has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Helix BioPharma to move above the current price in 90 days from now is about 76.89 (This Helix BioPharma Corp probability density function shows the probability of Helix Stock to fall within a particular range of prices over 90 days) .
Helix BioPharma Corp Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Helix BioPharma market risk premium is the additional return an investor will receive from holding Helix BioPharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Helix BioPharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Helix BioPharma's alpha and beta are two of the key measurements used to evaluate Helix BioPharma's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.11 | |||
| Standard Deviation | 5.36 | |||
| Variance | 28.78 | |||
| Risk Adjusted Performance | (0.01) |
Helix Stock Against Markets
Picking the right benchmark for Helix BioPharma stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Helix BioPharma stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Helix BioPharma is critical whether you are bullish or bearish towards Helix BioPharma Corp at a given time. Please also check how Helix BioPharma's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Helix BioPharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Helix BioPharma Corporate Directors
Helix BioPharma corporate directors refer to members of a Helix BioPharma board of directors. The board of directors generally takes responsibility for the Helix BioPharma's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Helix BioPharma's board members must vote for the resolution. The Helix BioPharma board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Albert Beraldo | Director | Profile | |
| Marek Orlowski | Independent Director | Profile | |
| Slawomir Majewski | Independent Director | Profile | |
| George Anders | Director | Profile |
How to buy Helix Stock?
Before investing in Helix BioPharma, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Helix BioPharma. To buy Helix BioPharma stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Helix BioPharma. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Helix BioPharma stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Helix BioPharma Corp stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Helix BioPharma Corp stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Helix BioPharma Corp, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Helix BioPharma Corp?
The danger of trading Helix BioPharma Corp is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Helix BioPharma is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Helix BioPharma. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Helix BioPharma Corp is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Helix BioPharma Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for Helix Stock analysis
When running Helix BioPharma's price analysis, check to measure Helix BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helix BioPharma is operating at the current time. Most of Helix BioPharma's value examination focuses on studying past and present price action to predict the probability of Helix BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helix BioPharma's price. Additionally, you may evaluate how the addition of Helix BioPharma to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |